Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 MacroGenicsKadmonViking TherapeuticsAkero TherapeuticsMagenta Therapeutics
SymbolNASDAQ:MGNXNYSE:KDMNNASDAQ:VKTXNASDAQ:AKRONASDAQ:MGTA
Price Information
Current Price$11.45$5.07$6.93$22.59$14.00
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$22.00$10.75$18.76$32.20$20.00
% Upside from Price Target92.14% upside112.11% upside170.74% upside42.54% upside42.86% upside
Trade Information
Market Cap$560.57 million$657.53 million$500.79 million$645.14 million$545.85 million
Beta2.322.472.35N/A3.35
Average Volume272,5051,603,470867,811110,09587,170
Sales & Book Value
Annual Revenue$60.12 million$1.40 millionN/AN/AN/A
Price / Sales9.32469.66N/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.75 per share$0.41 per share$4.17 per shareN/A$4.39 per share
Price / Book1.9912.37N/AN/AN/A
Profitability
Net Income$-171,450,000.00$-54,250,000.00$-22,060,000.00N/A$-57,510,000.00
EPS($4.19)($1.03)($0.40)N/A($3.13)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-303.08%-9,855.14%N/AN/AN/A
Return on Equity (ROE)-59.67%-188.03%-8.10%N/A-45.24%
Return on Assets (ROA)-44.82%-69.59%-7.94%N/A-41.44%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.11%0.54%N/AN/AN/A
Current Ratio4.79%2.29%46.71%22.32%17.16%
Quick Ratio4.79%2.29%46.71%22.32%17.16%
Ownership Information
Institutional Ownership Percentage92.99%88.95%55.18%66.57%65.41%
Insider Ownership Percentage7.88%2.85%3.49%N/A10.90%
Miscellaneous
Employees36411615859
Shares Outstanding48.96 million129.69 million72.26 million28.56 million38.99 million
Next Earnings Date2/25/2020 (Confirmed)3/5/2020 (Estimated)2/26/2020 (Confirmed)2/25/2020 (Estimated)3/17/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel